chr20-62840573-C-T
Variant names:
Variant summary
Our verdict is Benign. Variant got -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BS1BS2
The NM_001853.4(COL9A3):c.1896C>T(p.Asp632Asp) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0126 in 1,612,582 control chromosomes in the GnomAD database, including 171 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.0077 ( 9 hom., cov: 33)
Exomes 𝑓: 0.013 ( 162 hom. )
Consequence
COL9A3
NM_001853.4 synonymous
NM_001853.4 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -1.91
Genes affected
COL9A3 (HGNC:2219): (collagen type IX alpha 3 chain) This gene encodes one of the three alpha chains of type IX collagen, the major collagen component of hyaline cartilage. Type IX collagen, a heterotrimeric molecule, is usually found in tissues containing type II collagen, a fibrillar collagen. Mutations in this gene are associated with multiple epiphyseal dysplasia type 3. [provided by RefSeq, Jan 2010]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -21 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.56).
BP6
Variant 20-62840573-C-T is Benign according to our data. Variant chr20-62840573-C-T is described in ClinVar as [Benign]. Clinvar id is 258419.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr20-62840573-C-T is described in Lovd as [Benign].
BP7
Synonymous conserved (PhyloP=-1.91 with no splicing effect.
BS1
Variant frequency is greater than expected in population nfe. gnomad4 allele frequency = 0.00774 (1179/152342) while in subpopulation NFE AF= 0.0138 (941/68030). AF 95% confidence interval is 0.0131. There are 9 homozygotes in gnomad4. There are 536 alleles in male gnomad4 subpopulation. Median coverage is 33. This position pass quality control queck.
BS2
High Homozygotes in GnomAd4 at 9 AR gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
COL9A3 | NM_001853.4 | c.1896C>T | p.Asp632Asp | synonymous_variant | Exon 32 of 32 | ENST00000649368.1 | NP_001844.3 | |
COL9A3 | XM_047439893.1 | c.2073C>T | p.Asp691Asp | synonymous_variant | Exon 31 of 31 | XP_047295849.1 | ||
COL9A3 | XM_047439894.1 | c.1335C>T | p.Asp445Asp | synonymous_variant | Exon 32 of 32 | XP_047295850.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.00775 AC: 1179AN: 152224Hom.: 9 Cov.: 33
GnomAD3 genomes
AF:
AC:
1179
AN:
152224
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00690 AC: 1720AN: 249354Hom.: 13 AF XY: 0.00663 AC XY: 897AN XY: 135328
GnomAD3 exomes
AF:
AC:
1720
AN:
249354
Hom.:
AF XY:
AC XY:
897
AN XY:
135328
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0131 AC: 19061AN: 1460240Hom.: 162 Cov.: 31 AF XY: 0.0127 AC XY: 9208AN XY: 726484
GnomAD4 exome
AF:
AC:
19061
AN:
1460240
Hom.:
Cov.:
31
AF XY:
AC XY:
9208
AN XY:
726484
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00774 AC: 1179AN: 152342Hom.: 9 Cov.: 33 AF XY: 0.00719 AC XY: 536AN XY: 74500
GnomAD4 genome
AF:
AC:
1179
AN:
152342
Hom.:
Cov.:
33
AF XY:
AC XY:
536
AN XY:
74500
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
3
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:7
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:5
Jul 01, 2024
CeGaT Center for Human Genetics Tuebingen
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing
COL9A3: BP4, BP7, BS1, BS2 -
Mar 30, 2019
Athena Diagnostics
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing
- -
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing
- -
Jul 03, 2019
GeneDx
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing
- -
-
Breakthrough Genomics, Breakthrough Genomics
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: not provided
- -
not specified Benign:1
-
PreventionGenetics, part of Exact Sciences
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing
- -
Connective tissue disorder Benign:1
Feb 07, 2022
Genome Diagnostics Laboratory, The Hospital for Sick Children
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
RBP_binding_hub_radar
RBP_regulation_power_radar
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at